These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
354 related articles for article (PubMed ID: 22242645)
1. Bioequivalence of two omega-3 fatty acid ethyl ester formulations: a case of clinical pharmacology of dietary supplements. Galli C; Maggi FM; Risé P; Sirtori CR Br J Clin Pharmacol; 2012 Jul; 74(1):60-5. PubMed ID: 22242645 [TBL] [Abstract][Full Text] [Related]
2. Relative bioavailability and pharmacokinetics of two oral formulations of docosahexaenoic acid/eicosapentaenoic acid after multiple-dose administration in healthy volunteers. Rusca A; Di Stefano AF; Doig MV; Scarsi C; Perucca E Eur J Clin Pharmacol; 2009 May; 65(5):503-10. PubMed ID: 19148629 [TBL] [Abstract][Full Text] [Related]
3. Similar eicosapentaenoic acid and docosahexaenoic acid plasma levels achieved with fish oil or krill oil in a randomized double-blind four-week bioavailability study. Yurko-Mauro K; Kralovec J; Bailey-Hall E; Smeberg V; Stark JG; Salem N Lipids Health Dis; 2015 Sep; 14():99. PubMed ID: 26328782 [TBL] [Abstract][Full Text] [Related]
4. Steady-state bioavailability of prescription omega-3 on a low-fat diet is significantly improved with a free fatty acid formulation compared with an ethyl ester formulation: the ECLIPSE II study. Offman E; Marenco T; Ferber S; Johnson J; Kling D; Curcio D; Davidson M Vasc Health Risk Manag; 2013; 9():563-73. PubMed ID: 24124374 [TBL] [Abstract][Full Text] [Related]
5. A novel self-micro-emulsifying delivery system (SMEDS) formulation significantly improves the fasting absorption of EPA and DHA from a single dose of an omega-3 ethyl ester concentrate. Qin Y; Nyheim H; Haram EM; Moritz JM; Hustvedt SO Lipids Health Dis; 2017 Oct; 16(1):204. PubMed ID: 29037249 [TBL] [Abstract][Full Text] [Related]
6. A novel omega-3 free fatty acid formulation has dramatically improved bioavailability during a low-fat diet compared with omega-3-acid ethyl esters: the ECLIPSE (Epanova(®) compared to Lovaza(®) in a pharmacokinetic single-dose evaluation) study. Davidson MH; Johnson J; Rooney MW; Kyle ML; Kling DF J Clin Lipidol; 2012; 6(6):573-84. PubMed ID: 23312053 [TBL] [Abstract][Full Text] [Related]
7. Effects of a Self-micro-emulsifying Delivery System Formulation Versus a Standard ω-3 Acid Ethyl Ester Product on the Bioavailability of Eicosapentaenoic Acid and Docosahexaenoic Acid: A Study in Healthy Men and Women in a Fasted State. Maki KC; Palacios OM; Buggia MA; Trivedi R; Dicklin MR; Maki CE Clin Ther; 2018 Dec; 40(12):2065-2076. PubMed ID: 30454850 [TBL] [Abstract][Full Text] [Related]
8. Effects of Food on the Pharmacokinetics of Omega-3-Carboxylic Acids in Healthy Japanese Male Subjects: A Phase I, Randomized, Open-label, Three-period, Crossover Trial. Shimada H; Nilsson C; Noda Y; Kim H; Lundström T; Yajima T J Atheroscler Thromb; 2017 Sep; 24(9):980-987. PubMed ID: 28344197 [TBL] [Abstract][Full Text] [Related]
9. Bioequivalence Demonstration for Ω-3 Acid Ethyl Ester Formulations: Rationale for Modification of Current Guidance. Maki KC; Johns C; Harris WS; Puder M; Freedman SD; Thorsteinsson T; Daak A; Rabinowicz AL; Sancilio FD Clin Ther; 2017 Mar; 39(3):652-658. PubMed ID: 28189365 [TBL] [Abstract][Full Text] [Related]
10. Bioavailability of long chain omega-3 polyunsaturated fatty acids from phospholipid-rich herring roe oil in men and women with mildly elevated triacylglycerols. Cook CM; Hallaråker H; Sæbø PC; Innis SM; Kelley KM; Sanoshy KD; Berger A; Maki KC Prostaglandins Leukot Essent Fatty Acids; 2016 Aug; 111():17-24. PubMed ID: 27151222 [TBL] [Abstract][Full Text] [Related]
11. Risk stratification by the "EPA+DHA level" and the "EPA/AA ratio" focus on anti-inflammatory and antiarrhythmogenic effects of long-chain omega-3 fatty acids. Rupp H; Wagner D; Rupp T; Schulte LM; Maisch B Herz; 2004 Nov; 29(7):673-85. PubMed ID: 15580322 [TBL] [Abstract][Full Text] [Related]
12. Minimal food effect for eicosapentaenoic acid and docosahexaenoic acid bioavailability from omega-3-acid ethyl esters with an Advanced Lipid Technologies Lopez-Toledano MA; Thorsteinsson T; Daak AA; Maki KC; Johns C; Rabinowicz AL; Sancilio FD J Clin Lipidol; 2017; 11(2):394-405. PubMed ID: 28502496 [TBL] [Abstract][Full Text] [Related]
13. Systemic Bioavailability and Dose Proportionality of Omega-3 Administered in Free Fatty Acid Form Compared With Ethyl Ester Form: Results of a Phase 1 Study in Healthy Volunteers. Offman E; Davidson M; Abu-Rashid M; Chai P; Nilsson C Eur J Drug Metab Pharmacokinet; 2017 Oct; 42(5):815-825. PubMed ID: 28116646 [TBL] [Abstract][Full Text] [Related]
14. Incorporation of EPA and DHA into plasma phospholipids in response to different omega-3 fatty acid formulations--a comparative bioavailability study of fish oil vs. krill oil. Schuchardt JP; Schneider I; Meyer H; Neubronner J; von Schacky C; Hahn A Lipids Health Dis; 2011 Aug; 10():145. PubMed ID: 21854650 [TBL] [Abstract][Full Text] [Related]
17. Omega-3 fatty acid exposure with a low-fat diet in patients with past hypertriglyceridemia-induced acute pancreatitis; an exploratory, randomized, open-label crossover study. Dunbar RL; Gaudet D; Davidson M; Rensfeldt M; Yang H; Nilsson C; Kvarnström M; Oscarsson J Lipids Health Dis; 2020 May; 19(1):117. PubMed ID: 32473640 [TBL] [Abstract][Full Text] [Related]
18. Plasma oxylipins respond in a linear dose-response manner with increased intake of EPA and DHA: results from a randomized controlled trial in healthy humans. Ostermann AI; West AL; Schoenfeld K; Browning LM; Walker CG; Jebb SA; Calder PC; Schebb NH Am J Clin Nutr; 2019 May; 109(5):1251-1263. PubMed ID: 31006007 [TBL] [Abstract][Full Text] [Related]
19. The enteral bioavailability of eicosapentaenoic acid and docosahexaenoic acid is as good from ethyl esters as from glyceryl esters in spite of lower hydrolytic rates by pancreatic lipase in vitro. Krokan HE; Bjerve KS; Mørk E Biochim Biophys Acta; 1993 May; 1168(1):59-67. PubMed ID: 8504143 [TBL] [Abstract][Full Text] [Related]